COVID-19 Impact on Cancer Treatment in Healthcare Industry
The coronavirus pandemic has made an unbelievable effect on global economy system and as well as on daily lives of human beings. The impact on the healthcare sector has been adversely affected too and a huge burden is developed on already pinched healthcare sectors across the globe. Continuous research on coronavirus shows that the COVID-19 pandemic has elevated the psychological distress in both general population and among in high risk population.
Till now, July 2020, it became obvious that the novel strain of coronavirus or COVID -19 has major impact on the healthcare system in United States. The Surgeon General, American College of Surgeons and Centers for Medicare and Medicaid Services all are stated that the issue of delaying or cancelling of non-essential medical and surgical services to decreases the exposure risk of the virus and conserve resources for the expected large number of infected.
Researcher and oncologists should be curious or terrified because patients suffering from any type of cancer are at higher risk for bad outcomes. This is because of their immunity is very low due to taking cancer treatment and chemotherapy.
The impact of COVID-19 on cancer treatment market are describe by some pointers such as impact on patient mental health, impact on treatment, impact on ongoing care, impact on pharmaceutical supply chain, impact on drug price, impact on drug demand, impact on clinical research, impact on healthcare economy, strategic initiative taken by pharmaceutical industries and government and conclusion.
IMPACT OF COVID-19 ON PATIENT MENTAL HEALTH
Due to the people suffering from cancer may feel depressed due to home quarantine effect. Patients are also in fear of getting infected by the virus or they can’t survive if they are infected. There are hundreds and thousands of such patients who needed diagnosis, treatment and care, but are denied or delayed due to obvious reasons. Read in detail...